Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsVelpatasvir Intermediates

CAS 1335316 40 9 Velpatasvir Intermediates C13H22N2O5 99.0% Min cGMP standard

I'm Online Chat Now

CAS 1335316 40 9 Velpatasvir Intermediates C13H22N2O5 99.0% Min cGMP standard

China CAS 1335316 40 9 Velpatasvir Intermediates C13H22N2O5 99.0% Min cGMP standard supplier

Large Image :  CAS 1335316 40 9 Velpatasvir Intermediates C13H22N2O5 99.0% Min cGMP standard

Product Details:

Place of Origin: China
Certification: Meet with cGMP

Payment & Shipping Terms:

Minimum Order Quantity: 500Grams
Packaging Details: Drum
Contact Now
Detailed Product Description
Usage: Velpatasvir Intermediates CAS: 1335316-40-9
Molecular Formula: C13H22N2O5
High Light:

1378388 16 9

,

1438383 89 1

CAS : 1335316-40-9 Velpatasvir Intermediate C13H22N2O5 99.0% Min cGMP standard

 

Chemical Name : ( 5S ) - N - ( Methoxycarbonyl ) - L - valyl - 5 - methyl - L - proline

 

CAS No . : 1335316-40-9

 

Molecular Formula : C13H22N2O5

 

Molecular Weight : 286.32

 

Usage : Velpatasvir Intermediate

 

Description: 

 

Velpatasvir is innovated by Gilead to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients. Velpatasvir is a Direct-Acting Antiviral (DAA) medication used together with Sofosbuvir. The mechanism of action is as a Breast Cancer Resistance Protein Inhibitor, and P-Glycoprotein Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Organic Anion Transporting Polypeptide 2B1 Inhibitor. It blocks NS5A, a protein necessary for hepatitis C virus replication assembly.

 

( 5S ) - N - ( Methoxycarbonyl ) - L - valyl - 5 - methyl - L - proline CAS No . : 1335316-40-9 is an advanced intermediate of velpatasvir. There might be several synthesis routes to manufacture this intermediate but some routes or compounds are protected by the patents in some countries and regions. We strictly obey the laws and our products will not be sold to those areas protected by patents for commercial purposes. Anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.

 

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)